Loki Therapeutics

 NEWS

photo-1576086639808-ddfd21aa668c.jpeg

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Read More

March 24th, 2022


‘Trojan horse’ approach redirects tetanus immune response to tumors

March 24th, 2022


March 24th, 2022

Scientists test common bacteria as a weapon to target pancreatic tumors

Read More


Immunotherapy Gets Boost from Listeria Delivered Tetanus Toxoid, Shrinks Pancreatic Tumors in Mice

Read More

March 24th, 2022


March 24th, 2022

An Unlikely Pair: New Pancreatic Cancer Vaccine Utilizes Immunity from Tetanus


Novel therapeutic strategy shows promise against pancreatic cancer

Read More

March 23rd, 2022


February 11th, 2021

Press Release: Loki Therapeutics to Present at BIO CEO & Investor Digital Conference

Read More


Osmosis Podcast: Making Cancer Look Like Something Else - Christopher Bradley, Co-Founder and CEO of Loki Therapeutics

Listen Here

February 10th, 2021


MedCity News: Startup banks on immune-system memory to tackle cancer

Read More

January 27th,2021


December 16th 2020

Press Release: Loki Therapeutics to Participate in Biotech Showcase Digital, BIO @ JPM During "J.P. Morgan Week 2021"

Read More


October 9th 2020

Press Release: Loki Therapeutics to Present at 2020 BIO Investor Forum

Read More


September 5th, 2020

Leveraging Childhood Vaccination Recall to Fight Cancer with Chris Bradley Loki Therapeutics on Empowered Patient Podcast with Karen Jagoda

Listen Here


Health Professional Radio Interview

Listen Here

August 10th, 2020


Medtech Gurus Podcast: How To Transform Capital Into Value

Listen Here

August 5th, 2020


July 7th, 2020

BioTuesdays: Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

Read More


June 14th, 2020

Loki Therapeutics Forms Scientific Advisory Board to Advance Development of "Childhood Vaccination"-Based Cancer Therapeutics

Read More